Canna-Pharms Symbol logo.pngALS CANNABIS CLINIC BY CANNA PHARMS

New Innovative ALS Treatment at Canna Pharms Clinic

Developed By A Cannabis Expert Who Was Also Diagnosed With ALS in 2012

Discover cannabinoid treatments that have been helping patients facing conditions such as multiple sclerosis, ALS, Parkinson's and many more hard to treat neurological diseases.

Since 2015, Canna Pharms founder, diagnosed with ALS in 2012, has been dedicated to helping ALS patients live longer and restore a higher quality of life.

nih-nlm-ncbi--canna-pharms-als-clinic.png

" In light of the current findings, there is a valid rationale to propose the use of cannabinoid compounds in the pharmacological management of ALS patients. Cannabinoids indeed are able to delay ALS progression and prolong survival." ref; National Library of Medicine

Canna Pharms ALS Treatment Plan

 

         What is....

newest-Canna-Pharms-logo.pngCanna Pharms ALS New Cannabinoid Therapy Program

Over the last years, a growing interest was aimed to discovery new innovative and safer therapeutic approaches in the ALS treatment

Studies have found the bioactive compounds of Cannabis show powerful antioxidant, anti-inflammatory and neuroprotective effects in preclinical models of central nervous system disease. Therefore, It's clear Cannabinoid Therapy is a promising treatment for those suffering from ALS and other neurological disorders.

Canna Pharms studies have shown Implementing Cannabinoid Therapy swiftly and aggressively early after symptom onset has the best potential to slow or even halt the progression of most all symptoms ultimately extending a patients lives by over 10yrs. Starting Cannabinoid Therapy immediately after diagnosis has shown to be more effective in slowing progression of the disease.

CHAT WITH AN EXPERT HERE NOW

Canna-Pharms Symbol logo.pngCanna Pharms Has Been Treating ALS Patients with

Cannabinoid Therapy For Over 12 Years

ALS Cannabis Clinic is dedicated to providing cutting-edge cannabinoid therapy tailored specifically for individuals diagnosed with Amyotrophic Lateral Sclerosis (ALS). This progressive neurodegenerative disease poses significant challenges, not only in terms of physical health but also in the emotional and psychological well-being of patients and their families. Recognizing the urgent need for effective management strategies, the clinic focuses on harnessing the therapeutic properties of cannabinoids known for their potential to alleviate symptoms and improve overall health. At ALS Cannabis Clinic, the primary goal is to slow the progression of ALS and enhance the quality of life for those affected by this debilitating condition. By developing personalized treatment plans, the clinic ensures that therapies are tailored to meet the specific needs and circumstances of each individual. This personalized care not only addresses the physical symptoms of ALS, such as muscle weakness and spasticity, but also considers the emotional and psychological aspects of living with a chronic illness. Patients are provided with comprehensive information about cannabinoid therapy, empowering them to make informed decisions about their health. By standing at the forefront of ALS management, ALS Cannabis Clinic is not only pioneering innovative treatment options but also offering hope to patients and their families. The clinic’s dedication to research and development in cannabinoid therapy contributes to a growing body of evidence supporting the use of cannabis in managing ALS symptoms. As the understanding of cannabinoids continues to evolve, ALS Cannabis Clinic remains committed to improving outcomes for individuals living with ALS. Through compassionate care, personalized treatment, and a focus on quality of life, the clinic is helping to pave the way for a brighter future for ALS patients.

amyotrophic-lateral-sclerosis.jpg

ALS.jpg

neuron-diagram.jpg

 

  Cannabinoid Therapy Oil

  • Blend of Phytocannabinoids
  • Oral Drops, taken two times daily
  • Flavorless, Alcohol free, THC free
  • No added colors or dyes, non-GMO

 

 

 

 

 

How Cannabinoids Work In The Fight Against ALS

Research suggests that ALS may involve a dysregulation or disruption of the endocannabinoid system. Studies show alterations in endocannabinoid levels and receptor activity within the affected areas of the spinal cord in ALS patients, indicating a potential imbalance of endocannabinoids. In the endocannabinoid system (ECS), a biological system composed of endocannabinoids, which are neurotransmitters that bind to cannabinoid receptors, and cannabinoid receptor proteins that are expressed throughout the central nervous system, the brain and peripheral nervous system.

Cannabinoid Therapy can be used to balance out existing deficiencies in the body’s endocannabinoid system prompting a reduction of excitotoxicity effects as well as reductions in neuroinflammation and oxidative cell injury, all of which are key to the preservation of motor neurons.

For More Information About The EndoCannabinoid System

Watch This Short Video

Most traditional medicines are focused only on the alleviation of ALS related symptoms and not on the control of the disease progression.

HOW CANNABINOID THERAPY IS EFFECTIVE IN TREATING SYMPTOMS OF ALS

The Cannabis plant, also known as marijuana, contains over 500 natural compounds and about 70 of these are classified as cannabinoids (Fischedick et al., 2009). The discovery of Δ9-tetrahydrocannabinol (THC) as the major psychoactive principle in Cannabis, as well as the identification of numerous non-psychoactive cannabinoids such as cannabidiol (CBD), cannabigerol (CBG), cannabinol (CBN), cannabichromene (CBC),Δ9-tetrahydrocannabivarin (Δ9-THCV) and cannabidivarin (CBDV), has led to a significant growth in research aimed at understanding the therapeutic effects of these compounds.

Individually isolated cannabinoids in the proper proportions are known to have unique, very powerful individual therapeutic benefits and in combination these create an entourage effect which has the ability to balance your endocannabinoid system ultimately enabling your natural body defense to slow ALS symptom progression and extend overall life expectancy by over 3 times the current averages.

Most People Diagnosed With ALS Die Of Respiratory Failure Within 3-5 Years Of the First Symptom Onset

 

At Canna-Pharms Symbol logo.pngCanna Pharms ALS Clinic

Being Diagnosed With ALS Is No Longer A Death Sentence

LIVING LONGER WITH ALS IS POSSIBLE

Treatment with Full Spectrum Cannabis Oil with elevated levels of cannabinol (CBN), a non-psychotropic cannabinoid, through its residual affinity to CB1 receptors, is able to delay significantly disease onset in ALS.

Research shows a significant delay in disease progression was found when CB1/CB2 cannabinoid receptor were activated through cannabinoid therapy in ALS mice beginning after onset of motor impairment and tremor.

Overall, the efficacy of cannabinoids in slowing ALS progression, in extending life expectancy and in reducing the overall gravity of the disease creating a higher quality of life is mainly due to activation of CB2 receptors.

When implemented immediately after symptom onset, Cannabinoid Therapy has shown promise in delaying further symptom onset, slowing overall disease progression and significantly prolonging a better quality of life for the ALS patient.

Starting Cannabinoid Therapy at first symptom onset has extended a patient of Canna Pharms life by over 15 years so far from symptom onset.

Starting Cannabinoid Therapy after diagnosis is helping Canna Pharms patients live longer by over 5 years and counting.

ALS Cannabis Clinic Cannabinoid Therapy Program

This product, developed by the founder of Canna Pharms, who is personally affected by ALS, aims to enhance the quality of life for individuals recently diagnosed with the condition. The custom-formulated oral drops utilize cannabinoid therapy, designed to complement existing treatment plans, offering a holistic approach to managing ALS and its associated symptoms. By integrating this innovative therapy into their regimen, patients may experience improved well-being and potentially extend their longevity, making it a valuable addition to contemporary ALS care strategies.

Cannabinoid Therapy Oil for ALS is a carefully crafted product aimed at assisting those diagnosed with Amyotrophic Lateral Sclerosis. This 30-day supply of oral drops is meant for daily consumption, with a suggested dosage of ten drops two times each day for the duration of your illness. Oral drops provide a dependable and consistent approach to cannabinoid therapy. The formulation seeks to relieve symptoms related to ALS, fostering overall wellness and improving the quality of life for patients.

Canna Pharms exclusive Cannabinoid Therapy for Amyotrophic Lateral Sclerosis (ALS) has demonstrated significant benefits, including a reduction in symptom severity and a deceleration of symptom onset. Patients often experience alleviated anxiety and diminished pain levels, contributing to an enhanced overall quality of life. This therapeutic approach offers a promising adjunct to traditional treatments, aiming to improve the well-being of individuals affected by this challenging condition.

Canna Pharms ALS Cannabis Clinic Cannabinoid Therapy offers a unique targeted approach to restore balance within the body’s endocannabinoid system, with targeted cannabinoids  we effectively address deficiencies that may contribute to excitotoxicity, neuroinflammation, and oxidative cell injury. This innovative cannabinoid therapy is essential for the preservation of motor neurons, promoting overall neurological health and function. Proven an effective tool in the battle against ALS.

 

 

 

 

 

 

New Patients for ALS Cannabis Clinic Start Here

Start Your ALS Cannabinoid Therapy Today

New Clients receive 10% off their first purchase. Use voucher code: NEWPATIENT

Fill in the forms online, provide specific detailed information about your diet, lifestyle, symptoms and personal info.

We build your personal Cannabinoid Profile Recommendation designed to ease your symptoms and slow your progression.

Choose between 1,3,6 or 12 month treatment plan. We custom produce the formula designed for your specific needs.

It is important to understand that the treatment is not a guaranteed cure for every disease. Patients may be denied for various reasons. The effectiveness of the therapy for a particular disease depends on multiple factors: duration of the illness, age of the patient, the existence of chronic conditions, hereditary predisposition, lifestyle, etc. We’re not here to sell or pressure you into treatment. If you're a suitable candidate, you’ll have the option to proceed with therapy, but the choice is entirely yours. No unrealistic promises. No hidden agendas. Just transparency and support.